Kunitomi, Yuji
Nakashima, Masayuki
Seki, Tomotsugu
Ide, Kazuki
Kawakami, Koji http://orcid.org/0000-0002-7477-4071
Article History
Received: 19 October 2020
Accepted: 16 December 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: Y. K is an company employee of Taiho Pharmaceutical Co., Ltd., Japan. K. K received advisory fees from Shin Nippon Biomedical Laboratories, Ltd., Japan, JMDC Inc., Japan, and LEBER Inc., Japan; holds stocks of Real World Data, Co., Ltd., Japan; and research funds from Sumitomo Dainippon Pharma Co., Ltd., Japan, Pfizer Inc., Japan, Stella Pharma Corporation., Japan, Cmic Co., Ltd., Japan, Suntory Beverage & Food Limited, Japan, Medical Platform Co., Ltd., Japan, Eisai Co., Ltd., Japan, Kyowa Hakko Kirin Co., Ltd., Japan, Mitsubishi Corporation, Japan, and Real World Data, Co, Ltd., Japan. The other authors have no direct or indirect conflicts of interest.
: This study was approved by the Ethics Committee of the Graduate School and Faculty of Medicine, Kyoto University (approval number: R1893, February 20, 2019). The study was performed according to the Ethical Guidelines for Medical and Health Research Involving Human Subjects by the Ministry of Health, Labor, and Welfare.
: The need for informed consent was exempted because anonymized data were used.
: All authors provided consent to publish this work.
: Not applicable.